Queen Mary Innovation
Innovative research should make a social and economic impact, both locally and globally. We think commercial tools can be one of the best ways to achieve this.
At QMI we protect and license Intellectual Property and build sustainable enterprises and social ventures to take Queen Mary’s research to the world.
We have big ambitions to help entrepreneurs from the full breadth of our university to grow and succeed.
So get in touch to learn how we can help you develop your idea, or how we can work together to turn these exciting innovations into commercial success and create a meaningful impact.
Featured spinouts
Procyon
Biomarker technologies for early cancer detection
ReFleks
Regenerative medicine for fixing joint damage to stop progression to osteoarthritis.
elcella
A unique nutrient-based appetite suppressant which releases your body’s natural ability to control your eating – based on a decade of scientific research.
Syntex
A new material for synthetic heart valves which will enable patients to live lives indistinguishable from having a healthy heart.
LANDR
AI-powered music mastering, distribution, plugins, collaboration, promotion and sample packs.
Ultima Forma
Extending the limits of product performance with advanced forming technology.
Kinomica
A diagnostic platform to help clinicians prescribe the right drug, for the right patient, at the right time.
Keratify
A more effective way to maintain skin in culture.
Tabletop R&D
AI-powered playtesting for designing better board games faster.
RoEx
Using AI to transform how musicians of all skill levels produce and record new music.
hVIVO
The world leader in human challenge studies to test infectious and respiratory products.
Pipeline highlights
Predicting patient response to arthritis treatment
The method uses deep molecular phenotyping and machine learning on a small biopsy taken from the patient’s joints.
Digital Twin of the Aorta
TAVR-AID is a digital twin of the aorta specific to each patient, which simulates blood flow and makes predictions using artificial intelligence.
Predicting Pre-Eclampsia
A new blood test for predicting pre-eclampsia just five to sixteen weeks into a pregnancy.
Predicting dementia nine years before symptoms
A new method for predicting dementia with over 80% accuracy and up to nine years before a diagnosis.
Enhancing the efficacy of immunotherapy in lung cancer
A new methodology for treating lung cancer – the leading cause of cancer deaths worldwide.
Single molecule biochips
Life-saving portable nanoscale biochips which can diagnose patients in real time so clinicians can intervene immediately to improve blood clotting and prevent fatal bleeding.
Novel Electronic Skin
An artificial, soft skin for use in robotics, which provides information on the physical properties of the objects with which it interacts.
A Peptide Therapy for Neovascular Eye Diseases
Angiogenesis is a leading cause of eye problems among over 50s – including blindness.
Toothpaste tablet
A toothpaste tablet that replaces non-biodegradable ingredients and packaging to cut polluting waste.
Upcoming events
Media training: Learn how to get your innovation noticed
Build confidence working with journalists, identify opportunities for media engagement, and learn how to explain your research and innovation in interviews. Take your interview skills to the next level with tailored broadcast training, learn to write compelling opinion pieces, and discover how to become a regularly quoted expert. Find out more
Contact QMI
If you would like to find out more information about our technologies or have any queries, please contact the relevant team member using our contact information found on our team profiles.